Sclerostin also functions as the main mediator of bone loss after SCI [26, 34], and SOST-deficient mice were resistant to cancellous hindlimbs, cortical bone deficits osteoporosis in the sublesional regions of the lower extremities after SCI [24]. Here, SOST is linked to osteoporosis.